HUTCHMED (China) Limited
HCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,465,124 | $3,077,448 | $2,504,156 | $5,561,475 |
| - Cash | $153,958 | $283,589 | $313,278 | $377,542 |
| + Debt | $89,820 | $86,131 | $27,008 | $38,983 |
| Enterprise Value | $2,400,986 | $2,879,990 | $2,217,886 | $5,222,916 |
| Revenue | $630,201 | $837,999 | $426,409 | $356,128 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Gross Profit | $281,317 | $453,552 | $115,306 | $97,894 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| EBITDA | $14,106 | $67,274 | -$401,106 | -$207,958 |
| % Margin | 2.2% | 8% | -94.1% | -58.4% |
| Net Income | $37,729 | $100,780 | -$360,835 | -$194,648 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS Diluted | 0.22 | 0.6 | -2.15 | -1.25 |
| % Growth | -63.3% | 127.9% | -72% | – |
| Operating Cash Flow | $497 | $219,258 | -$268,599 | -$204,223 |
| Capital Expenditures | -$17,933 | -$32,612 | -$36,664 | -$16,756 |
| Free Cash Flow | -$17,436 | $186,646 | -$305,263 | -$220,979 |